Myriad Genetics
MYGN
#6703
Rank
ยฃ0.49 B
Marketcap
ยฃ5.31
Share price
-3.27%
Change (1 day)
-54.47%
Change (1 year)

Myriad Genetics (MYGN) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ0.27 Billion

According to Myriad Genetics's latest financial reports the company has ยฃ0.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Myriad Genetics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ0.55 B-9.12%
2023-12-31$ยฃ0.61 B-16.04%
2022-12-31$ยฃ0.73 B2.12%
2021-12-31$ยฃ0.71 B
2020-06-30$ยฃ0.74 B-13.6%
2019-06-30$ยฃ0.85 B17.28%
2018-06-30$ยฃ0.73 B23.87%
2017-06-30$ยฃ0.59 B5.2%
2016-06-30$ยฃ0.56 B32.98%
2015-06-30$ยฃ0.42 B0.44%
2014-06-30$ยฃ0.42 B-12.3%
2013-06-30$ยฃ0.47 B18.27%
2012-06-30$ยฃ0.40 B14.72%
2011-06-30$ยฃ0.35 B-3.94%
2010-06-30$ยฃ0.36 B39.52%
2009-06-30$ยฃ0.26 B23.22%
2008-06-30$ยฃ0.21 B25.79%
2007-06-30$ยฃ0.17 B24.44%
2006-06-30$ยฃ0.13 B78.13%
2005-06-30$ยฃ76.69 M-19.43%
2004-06-30$ยฃ95.19 M-4.01%
2003-06-30$ยฃ99.16 M17.94%
2002-06-30$ยฃ84.08 M-14.73%
2001-06-30$ยฃ98.61 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Bio-Rad Laboratories
BIO
ยฃ5.04 B 1,707.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
ยฃ1.87 B 570.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
ยฃ0.21 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ4.53 B 1,524.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ38.42 B 13,651.07%๐Ÿ‡บ๐Ÿ‡ธ USA